Regarding our 38 clinical samples, we found that detecting miR-21 in urine using biosensors is more accurate for the differential diagnosis of PCa from BPH or healthy subjects when compared with the traditional approach involving the detection of PSA in blood (Figure 8). Here, KLK3 is linked to benign prostatic hyperplasia.